“Standards of Care in Diabetes,” referredto here as the Standards of Care, is in-tended to provide clinicians, researchers,policy makers, and other interested indi-viduals with the components of diabetescare, general treatment goals, and toolsto evaluate the quality of care.The ADA ...
Overall, the ADA's new guidelines for the diagnosis and treatment of diabetes in 2023 reflect the latest advances in diabetes care and emphasize the importance of a personalized, holistic approach to managing this chronic condition. Healthcare professionals are encouraged to familiarize themselves with...
ADA2023新颁布的糖尿病诊疗标准英文版 New Diabetes Diagnosis and Treatment Standards under ADA 2023 Introduction: The American Diabetes Association (ADA) has recently introduced updated guidelines for the diagnosis and treatment of diabetes in 2023. These standards aim to provide healthcare professionals ...
42. Baum A, Scarpa J, Bruzelius E, Tamler R, Basu S, Faghmous J. Targeting weight loss interventions to reduce cardiovascular complications of type 2 diabetes: a machine learning-based post-hoc analysis of heterogeneous treatment effects in the Look AHEAD trial. Lancet Diabetes Endocrinol 2017;...
[9]Taylor C,McCance DR,Chappell L,et al.Implementation of guidelines for multidisciplinary team management of pregnancy in women with pre-existing diabetes or cardiac conditions:results from a UK national survey[J].BMC Pregnancy Childbirth...
当临床医生为可能不符合指南所依据的研究中使用的资格标准的患者做出治疗决策时,医疗保健需要科学和艺术的结合(The science and art of health care come together when the clinician makes treatment decisions for a person who may not m...
guidelines for screening and diagnosis of CKD,glycemia monitoring,lifestyle therapies,treatment goals,and pharmacologic management,but also specifically emphasizes the importance of comprehensive care in which pharmacotherapy based on a foundation of healthy lifestyle. The consensus states seven core recommenda...
Results showed that all patients with hypertension and type 2 diabetes had been screened for M/P in accordance with ADA treatment guidelines; screening methods included the standard dipstick (34.8%), Micral 2 test strip (34.85%), or other (30.4%). In the treatment of type 2 diabetes, ...
other adverse treatment effects.A lower targetmay bereason- able, particularly when using pharmacological agents that are not associated with hypoglycaemic risk. Higher targets can be appropriate in cases of limited life expectancy, advanced complications or poor tolerability or if other factors such as...
The goal of treatment is now less than 130/80 mmHg if it can be reached safely. In 2012,easing of the systolic targetto 140 mmHg by the ADA caused some controversy. But, as Gabbay explained: "The evidence wasn't there 10 years ago. We stuck to the evidence at that time, although ...